Login
Israel-Hamas Conflict
Independence Day
South America
Floods
Social Media
Parade
Latin America
Boxing
World Cup
Soccer
Natural Disasters
Amazon
Cryptocurrency
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Drug Delivery Business image

News from Drug Delivery Business

Information about Drug Delivery Business

Where is Drug Delivery Business located?Drug Delivery Business's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Drug Delivery Business News

Long-Lasting Insulin Takes Another Step Forward with Latest Clinical Trial Results
Novo Nordisk · Charleston

Long-Lasting Insulin Takes Another Step Forward with Latest Clinical Trial Results

74% Center coverage: 30 sources
On Sunday in Chicago, Dr. Athena Philis-Tsimikas, vice president of San Diego’s Scripps Whittier Diabetes Institute in La Jolla, helped deliver positive news for the estimated 7 million Americans who take insulin every day to manage their type 2 diabetes. The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-…See the Story
LifePlus Establishes Global Clinical Validation for First-of-Its-Kind Non-Invasive Glucose and Cuffless BP Monitoring Device and Platform
San Jose, California · San Jose

LifePlus Establishes Global Clinical Validation for First-of-Its-Kind Non-Invasive Glucose and Cuffless BP Monitoring Device and Platform

100% Center coverage: 3 sources
SAN JOSE, Calif.--(BUSINESS WIRE)--Jun 23, 2025-See the Story
GlucoModicum's non-invasive CGM nears first filing
Finland · Finland

GlucoModicum's non-invasive CGM nears first filing

100% Center coverage: 1 sources
Finland's GlucoModicum thinks it is in the lead in the race to bring a non-invasive continuous glucose monitor (CGM) to market.See the Story

Chinese Companies Are Developing Advanced GLP-1 Drugs

100% Center coverage: 1 sources
The research and development of new pharmaceuticals is increasingly an international affair, something that recent discussion about how tariffs might affect drug prices has made very clear. And even as GLP-1 drugs like Ozempic and Wegovy gain in popularity, scientists all over the world are looking for even more advanced drugs to address diabetes and weight loss.Some of that research has involved companies based in the United States, including E…Pharma · ChinaSee the Story

Lifecare takes next steps in CGM implant development

A screenshot of the Lifecare implantable CGM technology from a company video. Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor (CGM) implant. The Norway-based company says it completed the initial electromagnetic compatibility (EMC) testing of electronics developed for its next-generation CGM implant. EMC testing ensures that the implant can operate reliably when surroun…Norway · NorwayRead Article

Convatec wins FDA approval for Parkinson's treatment infusion

Convatec announced today that it received FDA approval for the delivery of a Parkinson’s disease therapy through its Neria Guard infusion set. The FDA approved apomorphine hydrochloride for subcutaneous infusion for the treatment of Parkinson’s. London-based Convatec’s Neria Guard set delivers the therapy under the skin (subcutaneous) as a continuous infusion via a small portable infusion pump. It eliminates the need for an invasive surgical pro…United States · United StatesRead Article

CGM Usage Improves Glycemic, Psychosocial Outcomes for Type 1 Diabetes

Investigators assessed continuous glucose monitoring with behavioral intervention for patients with type 1 diabetes.Germantown, Maryland · GermantownSee the Story

Abbott Diabetes head talks Medtronic deal, exciting times ahead

EVP, Diabetes Care, Chris Scoggins. [Image courtesy of Abbott]For many, a partnership between Abbott (NYSE:ABT) and Medtronic (NYSE:MDT), two medtech giants and frequent competitors, would have seemed unlikely. The two companies battle for market share in a variety of spaces, including cardiac implants, vascular access, neuromodulation and more. They’ll continue to duke it out in those areas, but in diabetes, they’ve become collaborators. Last s…Chicago, IL · ChicagoRead Article

PharmaSens, SiBionics innovatively combine tech in new pump

The Niia Essential insulin patch pump. [Image from PharmaSens on LinkedIn]While many existing systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have something different to offer. Current automated insulin delivery platforms — like those offered by Insulet, Tandem Diabetes Care, Medtronic, Beta Bionics and Sequel Med Tech — link separate devices. The pump itself is either tubeless and placed o…Switzerland · SwitzerlandRead Article

Study backs Biolinq sensor in GLP-1 muscle loss prevention

The investigational intradermal glucose sensor. [Image courtesy of Biolinq]A new study has demonstrated proof of concept for a Biolinq continuous sensor in preventing muscle loss during GLP-1 therapy. Investigators presented findings as a late-breaking poster at the American Diabetes Association’s 85th Scientific Sessions in Chicago. Using a DNA-based bioreceptor (aptamer), Biolinq designed its sensor to detect phenylalanine, an essential amino …Chicago, IL · ChicagoRead Article

Next-gen Medtronic insulin pump reportedly set for FDA submission

Que Dallara will be the CEO of MiniMed [Image courtesy of Medtronic]BTIG analysts said today that MiniMed, the Medtronic (NYSE:MDT) diabetes business, has some significant pipeline updates. Marie Thibault, Sam Eiber and Alexandra Pang shared notes from their meeting with Que Dallara, soon-to-be CEO of the to-be separated Diabetes unit, at the American Diabetes Association’s 85th Scientific Sessions in Chicago. Among those updates, the company ex…Chicago, IL · ChicagoRead Article

Breaking News Topics Related to Drug Delivery Business

California, United States icon

California, United States

Stock Markets icon

Stock Markets

Diabetes icon

Diabetes

United States icon

United States

San Diego County icon

San Diego County

San Diego icon

San Diego

News
For You
SearchBlindspotLocal